LifeStance Health Group, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 667.51M | 859.54M | 1.06B | 1.25B | 1.42B | 13.9% | |
| Cost of Revenue | (466.00M) | (622.52M) | (753.57M) | (848.57M) | (963.19M) | 13.5% | |
Gross Profit | 201.51M | 237.02M | 302.10M | 402.40M | 461.10M | 14.6% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (433.73M) | (377.99M) | (410.79M) | (363.06M) | (382.20M) | 5.3% | |
| General & Administrative | (433.73M) | (377.99M) | (410.79M) | (363.06M) | (382.20M) | 5.3% | |
| Depreciation & Amortization | (54.14M) | (69.20M) | (80.44M) | (70.95M) | (54.75M) | -22.8% | |
Operating Income (EBIT) | -286.35M | -210.17M | -189.13M | -31.61M | 24.15M | -176.4% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (38.91M) | (19.93M) | (21.22M) | (26.54M) | (11.66M) | -56.1% | |
| Other Income/Expenses (Net) | -46.75M | -22.56M | -17.45M | -26.00M | -11.79M | -54.7% | |
Income Before Tax | -333.11M | -232.73M | -206.58M | -57.61M | 12.36M | -121.5% | |
| Income Tax Expense | (25.91M) | (17.17M) | (20.32M) | (170.00K) | (2.70M) | -1688.2% | |
Net Income | -307.20M | -215.56M | -186.26M | -57.44M | 9.66M | -116.8% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-1 | $-1 | $-1 | $-0 | $0 | -120.0% | |
| Weighted Avg Shares Outstanding | 327.52M | 355.28M | 367.46M | 379.15M | 386.02M | 1.8% | |
| Weighted Avg Shares Outstanding (Diluted) | 327.52M | 355.28M | 367.46M | 379.15M | 391.14M | 3.2% | |
EBITDA | -240.06M | -143.60M | -104.93M | 39.87M | 78.78M | 97.6% |
Explore LFST
LFST in the Healthcare
Mid Cap